CClinicalTrials.gg
WithdrawnNCT03756155Updated Apr 5, 2022

Isometric Intervention for Lateral Elbow Tendinopathy

A Phase 1/2 interventional study of isometric intervention in Lateral Elbow Tendinopathy, Elbow Pain and Elbows Tendonitis, sponsored by University of Minnesota. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-04-05.

Sponsored by University of Minnesota · Phase 1/2, Interventional, and Treatment

Why this study was withdrawn
PI no longer at the institution; departmental permission to deactivate study
Phase
Phase 1/2
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will be looking at people with lateral elbow tendinopathy (elbow pain). The goal is to determine if a one-time isometric intervention will positively change the level of pain and strength as compared to baseline measurements. After determining baseline strength and pain level, an intervention consisting of several trials of isometric hand/wrist contractions will be performed by the participant. Pain and strength will again be assessed immediately after the intervention.

Read the detailed description

Participants will be randomized into two different groups in 10 participant blocks, meaning after every 10 participants eligible and completing the study, there will be 5 participants assigned to each group. Group 1 will complete a protocol with 10 sets of 10 second isometric holds followed by 10 second rest intervals between sets. Each repetition will be performed as closely to the targeted 30%-40% value. Group 2 will complete a protocol with 5 sets of 20 second isometric holds followed by 20 second rest intervals between sets. Each repetition will be performed as closely to the targeted 30% value. Resistance for both testing conditions will be performed against the examiner's external resistance/against the Microfet hand held dynamometer. Immediately after the intervention, all participants will again repeat their maximal grip on their affected arm using the Jamar hand held dynamometer and will grade their pain level. (The protocol will be identical to the pre testing procedure from above). The pain score and force output will be obtained and documented. Once these steps are complete, testing will cease. All participants will be instructed to follow their referring provider's treatment intervention.

02

Conditions studied

  • Lateral Elbow Tendinopathy
  • Elbow Pain
  • Elbows Tendonitis
  • Elbow Sprain
  • Elbow Injury
03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

Browse Tendinopathy studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,184 studies on the registry; 195 are open to participants now.

Of its 132 completed or terminated interventional studies of FDA-regulated products, 91 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

    • 18 years old or older
  • Currently has lateral elbow pain
  • If bilateral lateral elbow pain is present, the more symptomatic side will be assessed
  • At the time of presentation, individuals have been evaluated as having clinical diagnosed LET for at least 4 weeks
  • AND: Positive pain response to at least two of the following tests:

    • Pain with palpation on the affected elbow
    • Pain with resisted wrist or middle finger extension
    • Pain while stretching the lateral forearm muscles (Mills Test)
    • At least 30% deficit of pain-free grip compared with the unaffected side

Exclusion criteria

Exclusion Criteria:

    • Radicular/Cervical conditions reproducing elbow symptoms
  • rheumatoid arthritis
  • Other elbow pathologies: bursitis, medial epicondylalgia, radial nerve entrapment, posterolateral rotary instability
  • History of fracture to the radius, ulna, or humerus with resultant deformity of the involved extremity
  • History of an injection within 6 months
  • Inability to place the shoulder, elbow and wrist in the required testing position
  • The affected elbow had been operated on
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Group 1

    Group 1 will complete a protocol with 10 sets of 10 second isometric holds followed by 10 second rest intervals between sets. Each repetition will be performed as closely to the targeted 30%-40% value.

    Procedure: isometric intervention

  • Experimental
    Group 2

    Group 2 will complete a protocol with 5 sets of 20 second isometric holds followed by 20 second rest intervals between sets. Each repetition will be performed as closely to the targeted 30% value.

    Procedure: isometric intervention

Interventions

  • Procedureisometric intervention

    The research participants will perform isometric repetitions against the hand held dynamometer

    Also known as: Midrofet hand held dynamometer

06

What researchers measure

Primary outcomes

  1. Assess efficacy: NRS

    To assess the immediate effects of an isometric intervention on pain levels for individuals with lateral elbow tendinopathy. The primary outcome measure that will be utilized is the Numeric Pain Rating Scale (NRS) which will measure pain intensity using the 11 point scale with values ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: Randomization through 12 months

Secondary outcomes

  1. Assess correlation between force output during max grip strength testing and reported pain levels

    To determine if there is a correlation between force output during max grip strength testing and reported pain levels, and to determine if there is a correlation between two different time under tension protocols and max grip strength and reported pain levels. The secondary outcome measure with be grip strength, both pain free and max grip strength which will be measured in pounds using a Jamar handheld dynamometer.

    Time frame: Randomization through 12 months

07

Study locations

1 site
  • University of Minnesota
    Minneapolis, Minnesota 55455, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03756155
Lead sponsor
University of Minnesota
Responsible party
Sponsor
First posted
Nov 28, 2018
Start date
Dec 31, 2018
Primary completion
Dec 31, 2019
Completion
Dec 31, 2020 (estimated)
Last update
Apr 5, 2022

Study contacts

Chee Vang, MD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion